The Optimal Approach to Surgical Management of Goblet Cell Carcinoid of the Appendix: A Systematic Review.

appendiceal neoplasm appendicectomy goblet cell carcinoid hemicolectomy survival analysis

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
14 Aug 2024
Historique:
received: 17 06 2024
revised: 05 08 2024
accepted: 06 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: epublish

Résumé

Goblet cell carcinoid (GCC) is a rare and poorly understood appendiceal neoplasm, exhibiting mixed histological and aggressive clinical features. Current guidelines recommend right hemicolectomy in all cases, although there is conflicting evidence that appendicectomy alone may be sufficient. This review aims to identify the optimal surgical management for appendiceal GCC. A systematic review was performed by searching MEDLINE, Embase, Scopus and the Cochrane Register of Controlled Trials. Randomised controlled trials, cohort studies or large case series (>5 patients) reporting clinical outcomes for patients undergoing surgical management of GCC of the appendix were included. Outcomes extracted included participant and tumour characteristics, type of surgery and survival data. A total of 1341 studies were retrieved. After duplicate removal, 796 titles were screened for relevance prior to abstract and full text review. A total of six studies were included for analysis, comprising 3177 patients-1629 females and 1548 males. The median age ranged from 51 to 72 years. A total of 2329 patients underwent right hemicolectomy, while 824 were treated with appendicectomy only. Overall, the included studies report increased survival in patients undergoing right hemicolectomy compared to appendicectomy alone. A meta-analysis was not possible due to insufficient data reported in the published literature to date. There is no consensus regarding the optimal surgical management of appendiceal GCC, as outcomes-based data comparing surgical interventions are lacking. It is possible that some patients with favourable features are overtreated. The absence of robust evidence to support a more conservative approach means that right hemicolectomy remains the standard of care for all patients, in keeping with current international guidelines. The rarity of this condition and limited data in the published studies remain barriers to evidence-based best clinical practice.

Identifiants

pubmed: 39202258
pii: diagnostics14161773
doi: 10.3390/diagnostics14161773
pmc: PMC11353492
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Ann Surg Oncol. 2018 Aug;25(8):2391-2399
pubmed: 29916007
World J Gastrointest Oncol. 2010 Jun 15;2(6):251-8
pubmed: 21160637
Neuroendocrinology. 2016;103(5):500-17
pubmed: 26356507
J Med Case Rep. 2018 Sep 24;12(1):275
pubmed: 30244681
World J Surg. 2005 Nov;29(11):1436-9
pubmed: 16136284
ScientificWorldJournal. 2013;2013:543696
pubmed: 23365545
Arch Pathol Lab Med. 2015 Jun;139(6):782-90
pubmed: 26030247
Ann Diagn Pathol. 2019 Dec;43:151401
pubmed: 31675676
Surg Oncol. 2015 Mar;24(1):47-53
pubmed: 25686643
Front Oncol. 2022 Jul 12;12:915028
pubmed: 35903705
Dis Colon Rectum. 2007 Mar;50(3):315-22
pubmed: 17195086
Ann Surg Oncol. 2021 Dec;28(13):8916-8925
pubmed: 34409541
Turk J Med Sci. 2018 Feb 23;48(1):68-73
pubmed: 29479957
Mod Pathol. 2003 Dec;16(12):1189-98
pubmed: 14681318
Ann Surg Oncol. 2006 Mar;13(3):370-6
pubmed: 16485156
J Surg Oncol. 2019 Dec;120(7):1096-1101
pubmed: 31592538
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Am J Surg Pathol. 2018 Jul;42(7):898-910
pubmed: 29579011
Pancreas. 2010 Aug;39(6):753-66
pubmed: 20664473
BMC Gastroenterol. 2023 Nov 17;23(1):398
pubmed: 37978348
Endocr Connect. 2018 Feb;7(2):268-277
pubmed: 29335251
J Surg Oncol. 2006 Oct 1;94(5):396-402
pubmed: 16967437
Am J Surg Pathol. 2008 Oct;32(10):1429-43
pubmed: 18685490
Am Surg. 2004 Jul;70(7):593-9
pubmed: 15279181
Endocrine. 2021 Sep;73(3):734-744
pubmed: 33891259
J Surg Oncol. 2011 Jun;103(8):790-5
pubmed: 21240989
Spartan Med Res J. 2020 Oct 30;5(2):13487
pubmed: 33655185
Neuroendocrinology. 2012;95(2):135-56
pubmed: 22262080

Auteurs

Mahmoud M Salama (MM)

Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
School of Medicine, University of Galway, H91T K33 Galway, Ireland.

Maeve A O'Neill (MA)

Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.

Éanna J Ryan (ÉJ)

Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.

Niall J O'Sullivan (NJ)

Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
School of Medicine, Trinity College Dublin, D02 PN40 Dublin, Ireland.

Timothy S Nugent (TS)

Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.

Hugo C Temperley (HC)

Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
School of Medicine, Trinity College Dublin, D02 PN40 Dublin, Ireland.

Brian J Mehigan (BJ)

Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
School of Medicine, University of Galway, H91T K33 Galway, Ireland.

John O Larkin (JO)

Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.

David Gallagher (D)

Trinity St. James's Cancer Institute, D08 NHY1 Dublin, Ireland.

Grainne O'Kane (G)

Trinity St. James's Cancer Institute, D08 NHY1 Dublin, Ireland.

Paul H McCormick (PH)

Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
School of Medicine, Trinity College Dublin, D02 PN40 Dublin, Ireland.

Michael E Kelly (ME)

Department of Surgery, St. James's Hospital, D08 NHY1 Dublin, Ireland.
School of Medicine, Trinity College Dublin, D02 PN40 Dublin, Ireland.
Trinity St. James's Cancer Institute, D08 NHY1 Dublin, Ireland.

Classifications MeSH